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The Update is a bi-weekly web 
newsletter published by the Iowa 
Department of Public Health’s 
Bureau of Family Health.  It is 
posted the second and fourth week 
of every month, and provides 
useful job resource information for 
departmental health care professionals, 
information on training opportunities, 
intradepartmental reports and 
meetings, and additional information 
pertinent to health care professionals.
January 10, 2010
Eat and Play the 
5-2-1 Way
The Iowa Department of Public Health 
and Iowa Health Systems have 
collaborated to develop 
www.eatplay521.com, an online 
pediatric obesity prevention toolkit for 
Iowa health care providers.
Components of the toolkit include:
•free continuing education online   
 module on motivational interviewing and supporting patients   
 in health behavior change
•community resource referral link to “Find a Registered Dietitian in  
 Your Area”
•brochures for patients and families centered around creative   
 nutrition and physical activity ideas
•quick links to AAP recommendations on childhood obesity   
 prevention
• “Kids, Teens and Families” link for you to give patients and families  
 that includes tips on nutrition and physical activity, feeding picky   
 eaters and eating healthy on a budget
•quick guide to Iowa provider reimbursement codes for overweight  
 and obesity - coming soon
The goal of Eat and Play the 5-2-1 Way is to assist providers in 
addressing childhood overweight and obesity in the real-time clinical 
setting.  Please pass this information along to colleagues, family and 
friends interested in decreasing childhood obesity in Iowa.
For more information, go to 
http:/ /www.eatplay521.com/index.html.
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December/January 
Edition of The Check-
Up
The Check-Up is a monthly 
health care reform newsletter 
designed to keep interested 
Iowans up to date on the 
progress of health reform 
initiatives.
The Check-Up will feature 
updates on activities of the 
health reform councils as 
authorized by HF 2539 (2008) 
including the Legislative Health 
Care Coverage Commission, 
activities related to the 
Federal Patient Protection and 
Affordable Care Act (HR 3590), 
and other activities related to 
the focus of the councils.
The Check-Up will be archived 
on the main IPDH health care 
reform website at www.idph.
state.ia.us/hcr_committees.
To view the December/
January edition of The Check-
Up, go to www.idph.state.
ia.us/IdphArchive/Archive.
aspx?channel=CheckUp.
IDPH Director - 
Dr. Mariannette 
Miller-Meeks, MD
Dr. Mariannette Miller-Meeks, MD, was 
appointed director of the Iowa Department 
of Public Health (IDPH) by Governor Terry 
Branstad in December 2010.  With experience 
in both academic and practical medicine, as well as leadership roles 
in numerous medical and service organizations, Dr. Miller-Meeks 
understands the challenges of promoting and protecting the health of 
Iowans.  Under Dr. Miller-Meeks’ leadership, the department will work 
with the legislature, public health organizations, health care providers 
and the community to maintain and advance the health of all Iowans.
Dr. Miller-Meeks completed her undergraduate degree in nursing at 
Texas Christian University, master’s degree education from University of 
Southern California, and her M.D. from The University of Texas Health 
Science Center before completing her specialization in opthamology.  
She served as the fi rst woman president of the Iowa Medical Society, 
was the fi rst woman on faculty in the Department of Opthamology at 
The University of Iowa, and was a councilor for Iowa to the American 
Academy of Opthamology.  Dr. Miller-Meeks is a 24-year veteran of the 
United States Army, both active and reserve service, and retired after 24 
years as a lieutenant colonel.
Dr. Miller-Meeks volunteered at a free medical clinic in Cedar Rapids 
helping families who have fallen on hard times and is also a CASA 
volunteer.  She and her husband, Curt, have two adult children.
2011 Iowa Governor’s Conference on 
Public Health
Registration is now open for the 2011 Iowa Governor’s 
Conference on Public Health, April 5-6 the Scheman 
Conference Center in Ames.
To download a registration form, go to www.iowapha.
org/Resources/Documents2011%20Iowa%20Governor’s
%20Conference%20on%20Public%20Health%20Confer
ence%20Brochure.pdf.
How many state contracts does Scott County Health Department (SCHD) 
hold?
SCHD, located in Davenport, holds ten state contracts, including Breastfeeding Peer Counseling, Care for 
Yourself, EMS System Development, farmer’s market, Grants to Counties, immunization services, lead, Local 
public health services, tobacco, and WIC.
How many programs does SCHD administer?
SCHD administers three programs - child health, dental health,the I-SmileTM program and subcontracts for the 
hawk-i program.
How many counties (rural /urban) does SCHD service in i ts various 
programs?
Scott County Health Department provides services for Scott County.
How many people does the SCHD employee?
Sixty.
A li t t le history about SCHD . . .and how long has SCHD been a Tit le V MH 
or CH contractor?
The City of Davenport Board of Health and the Scott County Board of Health merged in 1968 to become one.  
The SCHD was formed after this merger, in April of 1969, and has a 41 year history of service and is the health 
department for all of Scott County.
The newly formed SCHD assumed responsibility for many environmental and clinical related services in Scott 
County.  As the need arose, the board of health adopted regulations for setting guidelines and enforcement 
procedures for public health programs.
More recently, the SCHD has realigned its operation to provide essential public health services as defi ned 
under the Core Public Health Functions.  Along with Administrative Services, there are fi ve service areas:  
Clinical; Community Relations, Information and Planning; Environmental; Correctional Health; and Public 
Health Services.
continued on next page
Spotlight on: 
Scott County 
Health Dept.
Spotlight on Scott 
County Health 
Department continued
The SCHD is governed by the Scott County Board 
of Health, which consists of fi ve members appointed 
by the Board of Supervisors.  The fi ve members 
include a clinical research coordinator, internal 
medicine physician, retired PhD nurse faculty member, 
pediatrician and a veterinarian.
SCHD became the Title V MCH provider for Scott 
County in 2000.  The maternal health services were 
subcontracted to Edgerton Women’s Health Center 
from 2000 until 
September 30, 2010.  The child health services were subcontracted to Community Health Care, Inc. from 
2000 to 2008.  Presently the SCHD operates the child health program, including Care for Kids, Early ACCESS, 
I-SmileTM and Dental Direct Services.  The hawk-i component of the child health program is subcontracted to 
Community Health Care, Inc.
What populations does SCHD serve?
Our child health program serves children birth through twenty years who live in Scott County.  The majority 
of our clients are enrolled in Medicaid.  While the children we serve live in Scott County, being a bordering 
community to Illinois means that families move back-and-forth between states.  This movement can impact the 
continuity in delivering services to our clients.
The most common language spoken by our clients is English, followed by Spanish and Vietnamese.  The 
majority of our clients are Caucasian, followed by African American and Asian.  Approximately 63.8 percent of 
our clients have a medical home and 31.5 percent have a dental home.
What is a strength of the SCHD program, including any best practice(s)?
A particular strength of our child health program is the established relationship with partners in the community 
that enables us to link clients to needed services.  Our child health consultants and I-SmileTM coordinator 
maintain lists of current resources to help meet the needs of our clients.  The list includes physicians and 
dentists who accept new Medicaid clients, specialists who accept Medicaid, and food, clothing and heat 
assistance resources just to name a few.  Not only do we refer to resources in our community, but many 
agencies refer to our program as well.  In addition, our employees have established an excellent relationship 
with the school nurses.  This relationship is importance since often times school nurses are aware of the needs 
of their students and can work with our program staff to meet those needs.
continued on next page 
L to R: Edward Rivers (Executive Director); JaNan Less (Project 
Director, CH Coordinator); Teri Arnold (Fiscal); Tiffany Kennedy 
(CAReS Administrator)
Spotlight on Scott County Health Department 
continued
How has a family benefitted from a service provided by SCHD?
Families are being served on multiple levels through I-SmileTM.  Oral health education and promotion has given 
families clear and simple messages about how to assure oral health for their children and how to seek regular 
dental care.  Barriers to dental care for children continue to exist.  Once a family has made contact with the 
I-SmileTM coordinator, the process to overcome those barriers begins.  This can be illustrated by the following 
story of one particular client who was served by our agency.  (Real names are not used.)
Eight-year-old Hudson was referred to I-SmileTM by his school nurse who became concerned about the child’s 
complaints of tooth pain and the presence of visible holes and dark spots on his teeth.  The nurse called 
I-SmileTM and asked the I-SmileTM coordinator to call the parent.
The child’s mother, Ilene, a seasonal construction worker and single mother is worried about Hudson’s teeth, 
too.  The family has no health or dental coverage, and money is tight.  She tells the I-SmileTM coordinator that 
she has applied twice to hawk-i and been denied both times.  Hudson’s condition cannot wait for another 
application; he needs dental care now.  
The I-SmileTM coordinator explained that he may be eligible for a Title V dental voucher.  A dental voucher was 
issued to a local dentist who examined the child, prescribed an antibiotic, and let the I-SmileTM coordinator 
know that Hudson needed a pediatric dentist.
This gave mom and the I-SmileTM coordinator a little time to plan their next move.  The I-SmileTM coordinator 
encouraged the mom to call hawk-i and fi nd out why Hudson has been denied.  If needed, the I-SmileTM 
coordinator can issue a dental voucher to a pediatric dentist.
In the next week, the I-SmileTM coordinator tried to call Ilene several times to no avail.  A few weeks later she 
called.  It turns out she has been working overtime and was away from her phone during business hours.  She 
managed to call hawk-i, but the representative referred her to DHS.  Hudson’s mouth was starting to hurt 
again.  A dental voucher was issued to a pediatric dentist and the child was seen right away.  Another round 
of antibiotics was prescribed, and the pediatric dentist faxed over a copy of Hudson’s treatment plan.  It was 
enormous!  Every tooth in his little mouth needed treatment.  The cost was $4,197.  The I-SmileTM coordinator’s 
heart sank.  The dental voucher program could not cover it all.  The I-SmileTM coordinator needed to fi gure out 
why hawk-i was denied.
Winter had come, and the seasonal construction work was gone.  Ilene was not working, and unfortunately 
neither was her phone.  The school nurse was able to help us get in touch once again.  Ilene was overwhelmed 
by the cost of the treatment and she was ready to give up.  Together, the I-SmileTM coordinator and Ilene made 
conference calls to both DHS and hawk-i.  It turns out that someone had mistakenly entered the wrong denial 
code.  Instead of being denied for Medicaid, and accepted for hawk-i, a code was entered that denied Hudson 
for both.  The mistake was fi xed and he was covered!
continued on next page
There were still more bumps along the road.  In the end, Hudson got the dental care he needed, but it required 
the full spectrum of available services.  Without the I-SmileTM coordinator, Hudson’s needs would likely still be 
unmet today.
A li t t le about some of the MCH staff  at  SCHD . . .
JaNan Less, (Community Health Coordinator/Project Director for MCH program):  JaNan has served as 
the project director since October 2009 and is working to expand the services provided through Scott County’s 
child health program.  When JaNan isn’t working, she enjoys spending time with family and friends, traveling 
and learning new things.
Brianna Huber, (Child Health Consultant):  Brianna serves as a care coordinator for the child health program 
and has worked for SCHD for two years.  Brianna is the lead consultant for community outreach and marketing 
activities for the Care for Kids program.  Brianna is currently attending Western Illinois University in pursuit of a 
Master of Arts degree in Health Sciences with an emphasis in Public Health.  In her spare time, Brianna enjoys 
softball, and working on her properties.
Kari Elmer (Child Health Consultant):  Kari is also a child health consultant who serves as a care coordinator 
and has worked for SCHD for two years.  She is an Early ACCESS service coordinator.  Kari enjoys spending 
time with her family, reading and cooking.
Briana Boswell (Dental Hygienist):  Briana has been a dental hygienist for nearly 12 years and I-SmileTM 
coordinator in Scott County since the program’s onset, fi rst at Community Health Care, Inc., and later at the 
SCHD.  Briana enjoys biking, hiking and spending time with her husband and three children.
Teri Arnold (Administrative Offi ce Assistant):  Teri is the administrative offi ce assistant for the SCHD.  She 
has over 25 years of clerical experience.  Teri manages the fi scal components of the department’s contracts.  
Teri enjoys spending time with her grandkids, playing volleyball and tropical winter vacations.
Tiffany Kennedy (Community Health Consultant):  Tiffany has been a community health consultant with 
the SCHD for a little over six years.  She currently serves as the CAReS Administrator, prepares the Fee for 
Service validation reports, and monitors the programmatic aspects of the child health grant.  In her spare time, 
Tiffany likes to spend time with friends and family, watch movies, read and travel.
What are the two most effective strategies/best practices that have been 
used to improve children’s oral health?
The fi rst most effective and broad reaching strategies has been the development of the I-SmileTM Workgroup 
- a group of community partners that meets quarterly to discuss developments in children’s oral health in 
Scott County.  The group’s collaboration has led to a series of partnerships that have resulted in new and 
innovative efforts to improve children’s oral health in Scott County, including: trainings for medical and dental 
professionals, establishment of a dental voucher program and referrals network, and most recently the 
development of a volunteer dental hygiene workforce to assist with school dental screenings.
The second most effective strategy was the participation of our I-SmileTM coordinator in local Give Kids A Smile ® 
activities.  The I-SmileTM coordinator serves on the Give Kids A Smile ® (GKAS) Board with local dentists.  This 
opportunity provided a venue to to meet regularly and build relationships with the local dentists.  As the GKAS
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program went through some changes and restructuring, SCHD was able to serve as a resource and support 
and in doing so, earned the trust of local dentists.  GKAS participating dentists are now much more willing to 
accept I-SmileTM referrals throughout the year. 
What is SCHD’s greatest success with the I-SmileTM program?
The greatest success of the SCHD I-SmileTM program has been the ability to engage the community 
stakeholders to become part of the solution for meeting the oral health needs in Scott County.  We are fi nding 
that dentists and dental hygienists are contacting our I-SmileTM coordinator to fi nd out how they can play an 
active role in helping to address Scott County’s oral health needs.  As a county with a large population, it would 
be impossible to meet the oral health needs of our children without reaching out to other professionals as well.  
The relationships that have been established with physicians, school nurses, Head Start staff, early childhood 
workers, WIC clinics, Child Health Specialty Clinics, DHS and more has played a role in addressing our oral 
health needs.  These partnerships provide the infrastructure necessary to build a safety net for assuring that 
Scott County children have access to a dental home.
Delta Dental of Iowa Foundation 
Statewide Public Service Campaign 
Encourages Dental Visit  by 1
Children in Iowa don’t see their family dentist on average until they 
are 3 years old,1 when in fact it’s recommended that a child should 
go to the dentist by age 1 or within six months after the fi rst tooth 
erupts.2 
In honor of National Children’s Dental Health Month in February, 
the Delta Dental of Iowa Foundation is kicking off “Dentist by 1,” 
a statewide public service campaign to educate parents about 
the benefi ts of taking their children to the dentist by age 1 and to 
encourage them to schedule a visit.
As part of the campaign, the Delta Dental of Iowa Foundation is offering a free infant toothbrush* for children 
up to age 3 who have visited the dentist. Parents can complete a form at www.OralHealthIA.com to receive a 
toothbrush and be entered into a monthly drawing for a kids’ Sonicare® toothbrush.
Delta Dental will also provide educational materials to Iowa hospitals, clinics, pediatricians and OB-GYN offi ces. 
The Delta Dental of Iowa Foundation’s “Dentist by 1” campaign is supported by the Iowa Academy of Pediatric 
Dentistry, the Iowa Dental Association, the Iowa Department of Public Health, and University of Iowa College of 
Dentistry.  
Visit www.OralHealthIA.com to view a special section dedicated to the importance of visiting the dentist by age 1 
and for more tips on establishing good oral health habits for a lifetime of healthy smiles.
To request posters on the “Dentist by 1” campaign, please contact Cindi Neubauer at 515-261-5590 or send Cindi 
an e-mail at cneubauer@deltadentalia.com.  
1Delta Dental of Iowa 2010 Claims Data.
2American Academy of Pediatric Dentistry, the American Academy of Pediatrics and the American Dental Association.
* Infant toothbrushes will be given to the fi rst 10,000 people who complete the form on the Delta Dental of Iowa website at www.
OralHealthIA.com.
To view a Dentist by 1 poster,  go to page 13 of The UPdate. 
 
Oral Health Recent Events
Administration/Program Management
2011 Childhood Immunization Schedules
The recommended immunization schedules for persons aged 0 through 18 years and the catch-up 
immunization schedule have been approved by the Advisory Committee on Immunization Practices 
(ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians 
(AAFP).   See pages 14-16 of The Update to view the following three schedules released by the Centers 
for Disease Control and Prevention (CDC):
Recommended Immunization Schedule for Person Aged 0 through 6 Years
 Recommended Immunization Schedule for Person Aged 7 through 18 Years
Catch-up Immunization Schedule for Persons Aged 4 Months through 18 Years Who Start Late or  
  Who are More Than 1 Month Behind
Changes in the immunizations schedules for 2011 include:
Guidance has been added for the hepatitis B vaccine schedule for children who did not receive a  
  birth dose. 
 Information on use of 13-valent pneumococcal conjugate vaccine has been added. 
 Guidance has been added for administration of 1 or 2 doses of seasonal influenza vaccine based  
  upon the child’s history of monovalent 2009 H1N1 vaccination. 
 Use of tetanus and diphtheria toxoids, and acellular pertussis (Tdap) vaccine among children aged  
  7 through 10 years who are incompletely vaccinated against pertussis is addressed, and reference  
  to a specified interval between tetanus and diphtheria toxoids (Td) and Tdap vaccination has been  
  removed. 
 Footnotes for the use of human papillomavirus (HPV) vaccine have been condensed.  
 A routine 2-dose schedule of quadrivalent meningococcal conjugate vaccine (MCV4) for certain  
  persons at high risk for meningococcal disease, and recommendations for a booster dose of MCV4  
  have been added. 
 Guidance for use of Haemophilus influenzae type b (Hib) vaccine in persons aged 5 years and older 
  in the catch-up schedule has been condensed.
To access the MMWR containing the schedule, go to 
www.cdc.gov/mmwr/preview/mmwrhtml/mm6005a6.htm.
The National Childhood Vaccine Injury Act requires that health-care providers provide parents or 
patients with copies of Vaccine Information Statements (VIS) before administering each dose of the 
vaccines listed in the schedules.  Additional information is available from state health departments and 
from CDC at www.cdc.gov/vaccines/pubs/vis/default.htm.
Detailed recommendations for using vaccines are available from ACIP statements (at www.cdc.gov/
vaccines/pubs/acip-list.htm) and the 2009 Red Book.  Guidance regarding the Vaccine Adverse Event 
Reporting System form is available online at www.vaers.hhs.gov or by telephone (800-822-7967). 
National Public Health Week Apri l  4-10 “Safety is No 
Accident”
It only takes a moment for an injury to happen – a fall on a stair, a moment’s glance away from the 
road, a biking or sports-related injury, a medication mix-up. But it also takes just a moment to protect 
against injuries and make communities safer. The potential for injury is all around us.  Each year, 
nearly 150,000 people die from injuries, and almost 30 million people are injured seriously enough to 
go to the emergency room.
Injuries are not “accidents”, and we can prevent them from happening. Taking actions such as 
wearing a seatbelt, properly installing and using child safety seats, wearing a helmet and storing 
cleaning supplies in locked cabinets are important ways to proactively promote safety and prevent 
injuries.
For more than a decade, communities around the country have celebrated National Public Health 
Week each April by highlighting public health achievements and raising awareness of issues 
important to improving the public’s health.  Each year, the American Public Health Association 
(APHA), selects a different issue around which to rally together and focus efforts to protect the 
nation’s health. During NPHW 2011, APHA will continue its broad vision to make America the 
healthiest nation in one generation by raising awareness of the importance of injury and violence 
prevention through this year’s theme “Safety is No Accident: Live Injury-free.”   During National 
Public Health Week 2011 – April 4 – 10, 2011, we can work to educate Americans that “Safety is No 
Accident.”  Together, we can help Americans live injury-free in all areas of life: at work, at home, at 
play, in your community and anywhere people are on the move. We all need to do our part to prevent 
injuries and violence in our communities. 
The American Public Health Association’s 48-page National Public Health Week toolkit is now 
available at www.nphw.org/nphw11/pdf/2011NPHW_toolkit.pdf.  The 2011 Partner Toolkit aims to 
help you get involved.  In it you will fi nd fact sheets, media outreach materials, suggested community 
events, legislative information, and resources to use throughout National Public Health Week.  Start 
planning your NPHW event today!
Join us as we work together to create a safer and healthier 
nation.
Calendar
March 10, 2011
MCH Advisory Council Meeting, 1-3 p.m., Iowa 
Lutheran Hospital, Conference Room 1
March 28-29, 2011
Maternal Nutrition and Breastfeeding Workshop
*April 5-6, 2011
2011 Iowa Governor’s Conference on Public Health
Scheman Conference Center, Ames
June 9, 2011
MCH Advisory Council Meeting, 1-3 p.m., Iowa 
Lutheran Hospital, Conference Room 1
* Required meeting
FEBRUARY 
Contract Required 
Due Dates
15 - Due: Electronic 
Expenditure Workbooks
30 - Export WHIS Records to 
IDPH
 
Bureau of Family Health:  1-800-383-3826 
Teen Line:  1-800-443-8336 
Healthy Families Line:  1-800-369-2229 
FAX:  515-242-6013 
 
NAME PHONE E-MAIL 
Beaman, Janet 281-3052 jbeaman@idph.state.ia.us 
Boltz, Rhonda 281-4926 rboltz@idph.state.ia.us 
Borst, M. Jane 
(Bureau Chief) 281-4911 jborst@idph.state.ia.us 
Brown, Kim 281-3126 kbrown@idph.state.ia.us 
Connet, Andrew 281-7184 aconnet@idph.state.ia.us 
Cox, Jinifer 281-7085 jcox@idph.state.ia.us 
Dhooge, Lucia 281-7613 ldhooge@idph.state.ia.us 
Ellis, Melissa 242-5980 mellis@idph.state.ia.us 
Goebel, Patrick 281-3826 pgoebel@idph.state.ia.us 
Hageman, Gretchen 745-3663 ghageman@idph.state.ia.us 
Hinton, Carol 281-6924 chinton@idph.state.ia.us 
Hobert Hoch, Heather 281-6880 hhobert@idph.state.ia.us 
Hoffman, Andrea 281-7044 ahoffman@idph.state.ia.us 
Horak, Shelley 281-7721 shorak@idph.state.ia.us 
Horras, Janet 954-0647 jhorras@idph.state.ia.us 
Hummel, Brad 281-5401 bhummel@idph.state.ia.us 
Johnson, Marcus 242-6284 mjohnson@idph.state.ia.us 
Jones, Beth 333-1868 bjones@idph.state.ia.us 
Mathews, Renee 281-6071 rmathews@idph.state.ia.us 
McGill, Abby 281-3108 amcgill@idph.state.ia.us 
Miller, Lindsay 281-7368 lmiller@idph.state.ia.us 
Montgomery, Juli 242-6382 jmontgom@idph.state.ia.us 
O’Hollearn, Tammy 242-5639 tohollea@idph.state.ia.us 
Parker, Erin 725-2166 emparker@idph.state.ia.us 
Pearson, Analisa 281-7519 apearson@idph.state.ia.us 
Peterson, Janet 242-6388 jpeterso@idph.state.ia.us 
Piper, Kim 720-4925 kpiper@idph.state.ia.us 
Thorud, Jennifer 281-0219 jthorud@idph.state.ia.us 
Trusty, Stephanie 281-4731 strusty@idph.state.ia.us 
Vierling, Sonni 281-8287 svierlin@idph.state.ia.us 
West, PJ 725-2856 pjwest@idph.state.ia.us 
Wheeler, Denise 281-4907 dwheeler@idph.state.ia.us 
Wolfe, Meghan 242-6167 mwolfe@idph.state.ia.us 
Area code is 515 
Here’s a surprising fact: children should visit the dentist by age ı. In fact, before 
the first baby teeth even erupt, parents can take measures to help protect their 
little ones from the effects of dental disease.  
Childhood dental disease ranks as the most common chronic condition among 
children – even though cavities are nearly ı00% preventable.
Discover the small changes in dental habits – including visiting the dentist –  
that can have big effects on a child’s oral health. Visit  www.OralHealthIA.com  
to learn more.
Introduce your child to the dentist.
Before they can even say “Hello.”
Cavities are nearly  ı00% preventable.
Delta Dental of Iowa Foundation
This schedule includes recommendations in effect as of December 21, 2010. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and 
feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Considerations should include provider assessment, patient preference, 
and the potential for adverse events. Providers should consult the relevant Advisory Committee on Immunization Practices statement for detailed recommendations: http://www.cdc.gov/vaccines/
pubs/acip-list.htm. Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS) at http://www.vaers.hhs.gov or by 
telephone, 800-822-7967. 
1. Hepatitis B vaccine (HepB). (Minimum age: birth)
At birth:
• Administer monovalent HepB to all newborns before hospital discharge.
• If mother is hepatitis B surface antigen (HBsAg)-positive, administer HepB 
and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth.
• If mother’s HBsAg status is unknown, administer HepB within 12 hours 
of birth. Determine mother’s HBsAg status as soon as possible and, if 
HBsAg-positive, administer HBIG (no later than age 1 week).
Doses following the birth dose:
• The second dose should be administered at age 1 or 2 months. Monovalent 
HepB should be used for doses administered before age 6 weeks.
• Infants born to HBsAg-positive mothers should be tested for HBsAg and anti-
body to HBsAg 1 to 2 months after completion of at least 3 doses of the HepB 
series, at age 9 through 18 months (generally at the next well-child visit).
• Administration of 4 doses of HepB to infants is permissible when a combina-
tion vaccine containing HepB is administered after the birth dose.
• Infants who did not receive a birth dose should receive 3 doses of HepB on 
a schedule of 0, 1, and 6 months.
• The final (3rd or 4th) dose in the HepB series should be administered no 
earlier than age 24 weeks.
2. Rotavirus vaccine (RV). (Minimum age: 6 weeks)
• Administer the first dose at age 6 through 14 weeks (maximum age: 14 
weeks 6 days). Vaccination should not be initiated for infants aged 15 weeks 
0 days or older.
• The maximum age for the final dose in the series is 8 months 0 days
• If Rotarix is administered at ages 2 and 4 months, a dose at 6 months is 
not indicated.
3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
(Minimum age: 6 weeks)
• The fourth dose may be administered as early as age 12 months, provided 
at least 6 months have elapsed since the third dose.  
4. Haemophilus influenzae type b conjugate vaccine (Hib). (Minimum age: 
6 weeks)
• If PRP-OMP (PedvaxHIB or Comvax [HepB-Hib]) is administered at ages 2 
and 4 months, a dose at age 6 months is not indicated.
• Hiberix should not be used for doses at ages 2, 4, or 6 months for the pri-
mary series but can be used as the final dose in children aged 12 months 
through 4 years. 
5. Pneumococcal vaccine. (Minimum age: 6 weeks for pneumococcal conju-
gate vaccine [PCV]; 2 years for pneumococcal polysaccharide vaccine [PPSV])
• PCV is recommended for all children aged younger than 5 years. Administer 
1 dose of PCV to all healthy children aged 24 through 59 months who are 
not completely vaccinated for their age.
• A PCV series begun with 7-valent PCV (PCV7) should be completed with 
13-valent PCV (PCV13).
• A single supplemental dose of PCV13 is recommended for all children aged 
14 through 59 months who have received an age-appropriate series of PCV7.
• A single supplemental dose of PCV13 is recommended for all children aged 
60 through 71 months with underlying medical conditions who have received 
an age-appropriate series of PCV7.
• The supplemental dose of PCV13 should be administered at least 8 weeks 
after the previous dose of PCV7. See MMWR 2010:59(No. RR-11).
• Administer PPSV at least 8 weeks after last dose of PCV to children aged 
2 years or older with certain underlying medical conditions, including a 
cochlear implant. 
6. Inactivated poliovirus vaccine (IPV). (Minimum age: 6 weeks)
• If 4 or more doses are administered prior to age 4 years an additional dose 
should be administered at age 4 through 6 years.
• The final dose in the series should be administered on or after the fourth 
birthday and at least 6 months following the previous dose.
7. Influenza vaccine (seasonal). (Minimum age: 6 months for trivalent inactivat-
ed influenza vaccine [TIV]; 2 years for live, attenuated influenza vaccine [LAIV])
• For healthy children aged 2 years and older (i.e., those who do not have 
underlying medical conditions that predispose them to influenza complica-
tions), either LAIV or TIV may be used, except LAIV should not be given to 
children aged 2 through 4 years who have had wheezing in the past 12 months.
• Administer 2 doses (separated by at least 4 weeks) to children aged 6 months 
through 8 years who are receiving seasonal influenza vaccine for the first time 
or who were vaccinated for the first time during the previous influenza season 
but only received 1 dose.
• Children aged 6 months through 8 years who received no doses of monovalent 
2009 H1N1 vaccine should receive 2 doses of 2010–2011 seasonal influenza 
vaccine. See MMWR 2010;59(No. RR-8):33–34.
8. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months)
• The second dose may be administered before age 4 years, provided at least 
4 weeks have elapsed since the first dose. 
9. Varicella vaccine. (Minimum age: 12 months) 
• The second dose may be administered before age 4 years, provided at least 
3 months have elapsed since the first dose.
• For children aged 12 months through 12 years the recommended minimum 
interval between doses is 3 months. However, if the second dose was 
administered at least 4 weeks after the first dose, it can be accepted as valid.
10. Hepatitis A vaccine (HepA). (Minimum age: 12 months)
• Administer 2 doses at least 6 months apart.
• HepA is recommended for children aged older than 23 months who live in 
areas where vaccination programs target older children, who are at increased 
risk for infection, or for whom immunity against hepatitis A is desired.
11. Meningococcal conjugate vaccine, quadrivalent (MCV4). (Minimum age: 
2 years)
• Administer 2 doses of MCV4 at least 8 weeks apart to children aged 2 through 
10 years with persistent complement component deficiency and anatomic 
or functional asplenia, and 1 dose every 5 years thereafter.
• Persons with human immunodeficiency virus (HIV) infection who are vac-
cinated with MCV4 should receive 2 doses at least 8 weeks apart.
• Administer 1 dose of MCV4 to children aged 2 through 10 years who travel 
to countries with highly endemic or epidemic disease and during outbreaks 
caused by a vaccine serogroup.
• Administer MCV4 to children at continued risk for meningococcal disease 
who were previously vaccinated with MCV4 or meningococcal polysac-
charide vaccine after 3 years if the first dose was administered at age 2 
through 6 years.
Range of  
recommended 
ages for certain 
high-risk groups
Range of 
recommended 
ages for all 
children
Vaccine ▼ Age ► Birth
1
month
2
months
4
months
6
months
12
months
15
months
18
months
19–23
months
2–3
years
4–6
years
Hepatitis B1 HepB
Rotavirus2 RV RV RV2
Diphtheria, Tetanus, Pertussis3 DTaP DTaP DTaP see  footnote3
Haemophilus influenzae type b4 Hib Hib Hib4
Pneumococcal5 PCV PCV PCV
Inactivated Poliovirus6 IPV IPV
Influenza7
Measles, Mumps, Rubella8 see footnote8
Varicella9 see footnote9
Hepatitis A10
Meningococcal11
HepBHepB
DTaP DTaP
Hib
IPVIPV
MMR
VaricellaVaricella
MMR
PCV
HepA Series
MCV4
Influenza (Yearly)
PPSV
HepA (2 doses)
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years—United States • 2011
For those who fall behind or start late, see the catch-up schedule
The Recommended Immunization Schedules for Persons Aged 0 Through 18 Years are approved by the Advisory Committee on Immunization Practices 
(http://www.cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org). 
Department of Health and Human Services • Centers for Disease Control and Prevention
The Recommended Immunization Schedules for Persons Aged 0 Through 18 Years are approved by the Advisory Committee on Immunization Practices (http://www.
cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org).  
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This schedule includes recommendations in effect as of December 21, 2010. Any dose not administered at the recommended age should be administered at a 
subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. 
Considerations should include provider assessment, patient preference, and the potential for adverse events. Providers should consult the relevant Advisory Committee 
on Immunization Practices statement for detailed recommendations: http://www.cdc.gov/vaccines/pubs/acip-list.htm. Clinically significant adverse events that follow 
immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS) at http://www.vaers.hhs.gov or by telephone, 800-822-7967.
1. Tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap). 
(Minimum age: 10 years for Boostrix and 11 years for Adacel))
• Persons aged 11 through 18 years who have not received Tdap should receive 
a dose followed by Td booster doses every 10 years thereafter.
• Persons aged 7 through 10 years who are not fully immunized against 
pertussis (including those never vaccinated or with unknown pertussis vac-
cination status) should receive a single dose of Tdap. Refer to the catch-up 
schedule if additional doses of tetanus and diphtheria toxoid–containing 
vaccine are needed.
• Tdap can be administered regardless of the interval since the last tetanus 
and diphtheria toxoid–containing vaccine.
2. Human papillomavirus vaccine (HPV). (Minimum age: 9 years) 
• Quadrivalent  HPV vaccine (HPV4) or bivalent HPV vaccine (HPV2) is recom-
mended for the prevention of cervical precancers and cancers in females. 
• HPV4 is recommended for prevention of cervical precancers, cancers, and 
genital warts in females.
• HPV4 may be administered in a 3-dose series to males aged 9 through 18 
years to reduce their likelihood of genital warts. 
• Administer the second dose 1 to 2 months after the first dose and the third 
dose 6 months after the first dose (at least 24 weeks after the first dose).  
3. Meningococcal conjugate vaccine, quadrivalent (MCV4). (Minimum age: 
2 years)
• Administer MCV4 at age 11 through 12 years with a booster dose at age 16 years.
• Administer 1 dose at age 13 through 18 years if not previously vaccinated.
• Persons who received their first dose at age 13 through 15 years should receive 
a booster dose at age 16 through 18 years.
• Administer 1 dose to previously unvaccinated college freshmen living in a 
dormitory. 
• Administer 2 doses at least 8 weeks apart to children aged 2 through 10 years 
with persistent complement component deficiency and anatomic or functional 
asplenia, and 1 dose every 5 years thereafter.
• Persons with HIV infection who are vaccinated with MCV4 should receive 2 
doses at least 8 weeks apart.
• Administer 1 dose of MCV4 to children aged 2 through 10 years who travel to 
countries with highly endemic or epidemic disease and during outbreaks caused 
by a vaccine serogroup.
• Administer MCV4 to children at continued risk for meningococcal disease who 
were previously vaccinated with MCV4 or meningococcal polysaccharide vac-
cine after 3 years (if first dose administered at age 2 through 6 years) or after 5 
years (if first dose administered at age 7 years or older).
4. Influenza vaccine (seasonal). 
• For healthy nonpregnant persons aged 7 through 18 years (i.e., those who 
do not have underlying medical conditions that predispose them to influenza 
complications), either LAIV or TIV may be used.
• Administer 2 doses (separated by at least 4 weeks) to children aged 6 months 
through 8 years who are receiving seasonal influenza vaccine for the first 
time or who were vaccinated for the first time during the previous influenza 
season but only received 1 dose. 
• Children 6 months through 8 years of age who received no doses of mon-
ovalent 2009 H1N1 vaccine should receive 2 doses of 2010-2011 seasonal 
influenza vaccine. See MMWR 2010;59(No. RR-8):33–34.
5. Pneumococcal vaccines.  
• A single dose of 13-valent pneumococcal conjugate vaccine (PCV13) may 
be administered to children aged 6 through 18 years who have functional or 
anatomic asplenia, HIV infection or other immunocompromising condition, 
cochlear implant or CSF leak. See MMWR 2010;59(No. RR-11). 
• The dose of PCV13 should be administered at least 8 weeks after the previ-
ous dose of PCV7.
• Administer pneumococcal polysaccharide vaccine at least 8 weeks after the 
last dose of PCV to children aged 2 years or older with certain underlying 
medical conditions, including a cochlear implant. A single revaccination 
should be administered after 5 years to children with functional or anatomic 
asplenia or an immunocompromising condition.
6. Hepatitis A vaccine (HepA). 
• Administer 2 doses at least 6 months apart.
• HepA is recommended for children aged older than 23 months who live 
in areas where vaccination programs target older children, or who are at 
increased risk for infection, or for whom immunity against hepatitis A is 
desired.
7. Hepatitis B vaccine (HepB).
• Administer the 3-dose series to those not previously vaccinated. For those 
with incomplete vaccination, follow the catch-up schedule.
• A 2-dose series (separated by at least 4 months) of adult formulation 
Recombivax HB is licensed for children aged 11 through 15 years.
8. Inactivated poliovirus vaccine (IPV). 
• The final dose in the series should be administered on or after the fourth 
birthday and at least 6 months following the previous dose.
• If both OPV and IPV were administered as part of a series, a total of 4 doses 
should be administered, regardless of the child’s current age.
9. Measles, mumps, and rubella vaccine (MMR). 
• The minimum interval between the 2 doses of MMR is 4 weeks. 
10. Varicella vaccine. 
• For persons aged 7 through 18 years without evidence of immunity (see 
MMWR 2007;56[No. RR-4]), administer 2 doses if not previously vaccinated 
or the second dose if only 1 dose has been administered.
• For persons aged 7 through 12 years, the recommended minimum interval 
between doses is 3 months. However, if the second dose was administered 
at least 4 weeks after the first dose, it can be accepted as valid.
• For persons aged 13 years and older, the minimum interval between doses 
is 4 weeks.
Vaccine ▼ Age ► 7–10 years 11–12 years 13–18 years
Tetanus, Diphtheria, Pertussis1
Human Papillomavirus2 see footnote 2
Meningococcal3
Influenza4
Pneumococcal5
Hepatitis A6
Hepatitis B7
Inactivated Poliovirus8
Measles, Mumps, Rubella9
Varicella10
Tdap
HPV (3 doses)(females)
MCV4MCV4
Tdap
HPV series
MCV4
Influenza (Yearly)
Pneumococcal
HepA Series
Hep B Series
IPV Series
MMR Series
Varicella Series
Range of 
recommended 
ages for 
catch-up
immunization
Range of 
recommended 
ages for all 
children
Range of  
recommended 
ages for certain 
high-risk groups
Recommended Immunization Schedule for Persons Aged 7 Through 18 Years—United States • 2011
For those who fall behind or start late, see the schedule below and the catch-up schedule
1. Hepatitis B vaccine (HepB).
•	 Administer	the	3-dose	series	to	those	not	previously	vaccinated.
•	 The	minimum	age	for	the	third	dose	of	HepB	is	24	weeks.
•	 A	2-dose	series	(separated	by	at	least	4	months)	of	adult	formulation	Recombivax	
HB	is	licensed	for	children	aged	11	through	15	years.
2. Rotavirus vaccine (RV).
•	 The	maximum	age	for	the	first	dose	is	14	weeks	6	days.	Vaccination	should	not	
be	initiated	for	infants	aged	15	weeks	0	days	or	older.
•	 The	maximum	age	for	the	final	dose	in	the	series	is	8	months	0	days.
•	 If	Rotarix	was	administered	for	the	first	and	second	doses,	a	third	dose	is	not	
indicated.
3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).
•	 The	fifth	dose	 is	not	necessary	 if	 the	 fourth	dose	was	administered	at	age	4	
years	or	older.
4. Haemophilus influenzae type b conjugate vaccine (Hib).
•	 1	dose	of	Hib	vaccine	should	be	considered	for	unvaccinated	persons	aged	5	
years	or	older	who	have	sickle	cell	disease,	leukemia,	or	HIV	infection,	or	who	
have	had	a	splenectomy.
•	 If	the	first	2	doses	were	PRP-OMP	(PedvaxHIB	or	Comvax),	and	administered	at	
age	11	months	or	younger,	the	third	(and	final)	dose	should	be	administered	at	
age	12	through	15	months	and	at	least	8	weeks	after	the	second	dose.
•	 If	the	first	dose	was	administered	at	age	7	through	11	months,	administer	the	
second	dose	at	least	4	weeks	later	and	a	final	dose	at	age	12	through	15	months.
5. Pneumococcal vaccine.
•	 Administer	1	dose	of	13-valent	pneumococcal	conjugate	vaccine	(PCV13)	to	all	
healthy	children	aged	24	through	59	months	with	any	incomplete	PCV	schedule	
(PCV7	or	PCV13).
•	 For	 children	aged	24	 through	71	months	with	underlying	medical	 conditions,	
administer	 1	 dose	 of	PCV13	 if	 3	 doses	 of	PCV	were	 received	 previously	 or	
administer	2	doses	of	PCV13	at	 least	8	weeks	apart	 if	 fewer	than	3	doses	of	
PCV	were	received	previously.
•	 A	single	dose	of	PCV13	 is	 recommended	 for	certain	children	with	underlying	
medical	conditions	through	18	years	of	age.	See	age-specific	schedules	for	details.
•	 Administer	 pneumococcal	 polysaccharide	 vaccine	 (PPSV)	 to	 children	aged	2	
years	or	older	with	certain	underlying	medical	conditions,	including	a	cochlear	
implant,	at	least	8	weeks	after	the	last	dose	of	PCV.	A	single	revaccination	should	
be	administered	after	5	years	to	children	with	functional	or	anatomic	asplenia	or	
an	immunocompromising	condition.	See	MMWR	2010;59(No.	RR-11).
6. Inactivated poliovirus vaccine (IPV).
•	 The	final	dose	in	the	series	should	be	administered	on	or	after	the	fourth	birthday	
and	at	least	6	months	following	the	previous	dose.
•	 A	fourth	dose	is	not	necessary	if	the	third	dose	was	administered	at	age	4	years	
or	older	and	at	least	6	months	following	the	previous	dose.
•	 In	the	first	6	months	of	life,	minimum	age	and	minimum	intervals	are	only	recom-
mended	if	 the	person	is	at	risk	for	 imminent	exposure	to	circulating	poliovirus	
(i.e.,	travel	to	a	polio-endemic	region	or	during	an	outbreak).
7. Measles, mumps, and rubella vaccine (MMR).
•	 Administer	the	second	dose	routinely	at	age	4	through	6	years.	The	minimum	
interval	between	the	2	doses	of	MMR	is	4	weeks.
8. Varicella vaccine.
•	 Administer	the	second	dose	routinely	at	age	4	through	6	years.	
•	 If	the	second	dose	was	administered	at	least	4	weeks	after	the	first	dose,	it	can	
be	accepted	as	valid.
9. Hepatitis A vaccine (HepA).
•	 HepA	is	recommended	for	children	aged	older	than	age	23	months	who	live	in	
areas	where	vaccination	programs	target	older	children,	or	who	are	at	increased	
risk	for	infection,	or	for	whom	immunity	against	hepatitis	A	is	desired.
10. Tetanus and diphtheria toxoids (Td) and tetanus and diphtheria toxoids and 
acellular pertussis vaccine (Tdap).
•	 Doses	of	DTaP	are	counted	as	part	of	the	Td/Tdap	series.
•	 Tdap	should	be	substituted	 for	a	single	dose	of	Td	 in	 the	catch-up	series	 for	
children	aged	7	through	10	years	or	as	a	booster	for	children	aged	11	through	18	
years;	use	Td	for	other	doses.
11. Human papillomavirus vaccine (HPV).
•	 Administer	 the	series	 to	 females	at	age	13	 through	18	years	 if	not	previously	
vaccinated	or	have	not	completed	the	vaccine	series.
•	 Quadrivalent	HPV	vaccine	(HPV4)	may	be	administered	in	a	3-dose	series	to	
males	aged	9	through	18	years	to	reduce	their	likelihood	of	genital	warts.	
•	 Use	recommended	routine	dosing	intervals	for	series	catch-up	(i.e.,	the	second	
and	third	doses	should	be	administered	at	1	 to	2	and	6	months	after	 the	first	
dose).	The	minimum	interval	between	the	first	and	second	doses	is	4	weeks.	The	
minimum	interval	between	the	second	and	third	doses	is	12	weeks,	and	the	third	
dose	should	be	administered	at	least	24	weeks	after	the	first	dose.
Information	about	reporting	reactions	after	immunization	is	available	online	at	http://www.vaers.hhs.gov	or	by	telephone,	800-822-7967.	Suspected	cases	of	vaccine-preventable	diseases	should	be	reported	to	the	
state	or	local	health	department.	Additional	information,	including	precautions	and	contraindications	for	immunization,	is	available	from	the	National	Center	for	Immunization	and	Respiratory	Diseases	at		
http://www.cdc.gov/vaccines	or	telephone,	800-CDC-INFO	(800-232-4636).
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PERSONS AGED 4 MONTHS THROUGH 6 YEARS
Vaccine Minimum Age for Dose 1
Minimum Interval Between Doses
Dose 1 to Dose 2 Dose 2 to Dose 3 Dose 3 to Dose 4 Dose 4 to Dose 5
Hepatitis	B1 Birth 4 weeks 8 weeks(and	at	least	16	weeks	after	first	dose)
Rotavirus2 6	wks 4 weeks 4 weeks2
Diphtheria,	Tetanus,	Pertussis3 6	wks 4 weeks 4 weeks 6 months 6 months3
Haemophilus influenzae type	b4 6	wks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
8 weeks (as final dose)
if	first	dose	administered	at	age	12–14	months
No further doses needed
if	first	dose	administered	at	age	15	months	or	older
4 weeks4
if	current	age	is	younger	than	12	months
8 weeks (as final dose)4
if	current	age	is	12	months	or	older	and first	dose	
administered	at	younger	than	age	12	months	and	
second	dose	administered	at	younger	than	15	months
No further doses needed
if	previous	dose	administered	at	age	15	months	or	older
8 weeks (as final dose)
This	dose	only	necessary	
for	children	aged	12	months	
through	59	months	who	
received	3	doses	before	
age	12	months
Pneumococcal5 6	wks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
8 weeks (as final dose for healthy children)
if	first	dose	administered	at	age	12	months	or	older	
or	current	age	24	through	59	months
No further doses needed
for	healthy	children	if	first	dose	
administered	at	age	24	months	or	older
4 weeks
if	current	age	is	younger	than	12	months
8 weeks
(as final dose for healthy children)
if	current	age	is	12	months	or	older
No further doses needed
for	healthy	children	if	previous	dose	administered	at	age	
24	months	or	older
8 weeks (as final dose)
This	dose	only	necessary	
for	children	aged	12	months	
through	59	months	who		
received	3	doses	before	age	
12	months	or	for	children	
at	high	risk	who	received	3	
doses	at	any	age
Inactivated	Poliovirus6 6	wks 4 weeks 4 weeks 6 months6
Measles,	Mumps,	Rubella7 12	mos 4 weeks
Varicella8 12	mos 3 months
Hepatitis	A9 12	mos 6 months
PERSONS AGED 7 THROUGH 18 YEARS
Tetanus,Diphtheria/	
Tetanus,Diphtheria,Pertussis10 7	yrs
10 4 weeks
4 weeks
if	first	dose	administered	at	younger	than	age	12	months
6 months
if	first	dose	administered	at	12	months	or	older
6 months
if	first	dose	administered	at	
younger	than	age	12	months
Human	Papillomavirus11 9	yrs Routine dosing intervals are recommended (females)11
Hepatitis	A9 12	mos 6 months
Hepatitis	B1 Birth 4 weeks 8 weeks(and	at	least	16	weeks	after	first	dose)
Inactivated	Poliovirus6 6	wks 4 weeks 4 weeks6 6 months6
Measles,	Mumps,	Rubella7 12	mos 4 weeks
Varicella8 12	mos
3 months
if	person	is	younger	than	age	13	years
4 weeks
if	person	is	aged	13	years	or	older
The table below provides catch-up schedules and minimum intervals between doses for children whose vaccinations have been delayed. A vaccine 
series does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the child’s age
Catch-up Immunization Schedule for Persons Aged 4 Months Through 18 Years Who Start Late or Who Are More Than 1 Month Behind—United States • 2011
